Mirati

Filter by Popularity: - - - -
Searching for "Mirati"
Thumbnail
Mirati Therapeutics, Inc. (Nasdaq: MRTX) today announced the pricing of an underwritten public offering of 1,612,903 shares of its common stock at a... [Read More]
Mirati Therapeutics (MRTX) is down 5% after hours in response to its announced $75M public offering of common stock. Price, volume and terms have yet to be... [Read More]
Tags: Mirati - Price - $75M
Thumbnail
Mirati Therapeutics, Inc. (Nasdaq: MRTX) today announced that it intends to offer and sell, subject to market and other conditions, $75.0 million of shares of... [Read More]
Thumbnail
Get the latest San Diego news. CBS News 8 is the local source for San Diego breaking news, top stories, weather, traffic, sports, entertainment and... [Read More]
Dosing is underway in a Phase 1/2 clinical trial evaluating Mirati Therapeutics' (MRTX) KRAS G12C inhibitor MRTX849 in patients with KRAS G12C mutation-pos... [Read More]
Jump To: